Skip to content

Clinical trials

Conversion Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Conversion Disorder Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20072
20081
20161
20172
20182
20191
20201
20221
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Active, not recruiting2
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)4
Rhode Island Hospital3
Massachusetts General Hospital2
The Cleveland Clinic2
Brigham and Women's Hospital1
Mayo Clinic1
Medical University of South Carolina1
National Institutes of Health Clinical Center (CC)1
Providence VA Medical Center1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conversion Disorder20
Seizures7
Psychogenic Nonepileptic Seizures5
Stress Disorders, Post-Traumatic3
Epilepsy2
Movement Disorders2
Parkinson Disease2
Anxiety Disorders1
Brain Concussion1
Brain Injuries, Traumatic1

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.